Finance

Beta
Lists
CPMD:OTCMKTS
Cannapharmarx Inc
$0.00070
-73.08%
(-0.0019) 1D
Jun 12, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CPMD...
Open
$0.00
High
$0.00
Low
$0.00
Mkt. cap
474.95K
Avg. vol.
241.94K
Volume
798.18K
52-wk high
$0.01
52-wk low
$0.00
EPS
-$0.02
Beta
2.44
Shares outstanding
678.50M
No. of employees
26
Open
$0.00
High
$0.00
Low
$0.00
Mkt. cap
474.95K
Avg. vol.
241.94K
Volume
798.18K
52-wk high
$0.01
52-wk low
$0.00
EPS
-$0.02
Beta
2.44
Shares outstanding
678.50M
No. of employees
26
News stories
From sources across the web
About Cannapharmarx Inc
CEO-
Employees26
Founded1998
HeadquartersCalgary, Alberta, Canada
SectorPharmaceutical industry
Websitecannapharmarx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
231.61K
656.61K
138.63K
627.46K
Cost of goods sold
852.82K
1.33M
673.44K
1.17M
Cost of revenue
852.82K
1.33M
673.44K
1.17M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
164.17K
261.43K
358.75K
141.67K
Operating expense
164.17K
261.43K
358.75K
141.67K
Total operating expenses
1.02M
1.59M
1.03M
1.31M
Operating income
-785.38K
-935.65K
-893.55K
-682.34K
Other non operating income
-56.00K
175.65K
-1.65M
1.12M
EBT including unusual items
-1.41M
-1.48M
-7.55M
-382.02K
EBT excluding unusual items
-1.41M
-1.48M
-3.03M
-382.02K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.41M
-1.48M
-7.55M
-382.02K
Net profit margin
-610.28%
-225.07%
-5,445.85%
-60.88%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-657.52K
-693.57K
-482.81K
-787.16K
Net interest expenses
-657.52K
-693.57K
-482.81K
-787.16K
Depreciation and amortization charges
-
-
-
-
EBITDA
-785.38K
-
-
-682.34K
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer